Nutrien Ltd (NTR) reports robust fertilizer sales and sustainability progress, while navigating pricing pressures and ...

TGS ASA (TGSGY) reports a 19% revenue increase, surpasses merger synergy targets, and announces an 11% dividend hike amid ...

Healius Ltd (ASX:HLS) reports a robust 10% increase in group revenue, with significant gains in pathology and imaging, while addressing challenges in labor costs and strategic transitions.

In 2024, a total of DKK 599m was distributed to shareholders. For 2025, the Board of Directors proposes to the annual general ...

Our DCF-derived fair value estimate for IPH is AUD 5.60 per share. At our fair value, this translates to a fiscal 2025 price/adjusted earnings ratio of 11 times and a dividend yield of about 7%. We ...

Ad Hoc Announcement Pursuant to Article 53 of the SIX Exchange Regulation Listing Rules SIKA WITH RECORD RESULTS -- JUMP IN NET PROFIT OF 17.4% ...

Glencore's strategic focus on profit, risk management, and shareholder value makes it a compelling investment, with ...

Mineral Resources is in only reasonable financial health. Comparatively high current debt levels in conjunction with low lithium prices are somewhat of a concern, though in keeping with Mineral ...

Gap's Ba2 CFR reflects its solid credit metrics and very good liquidity. The company's debt/EBITDA improved to 2.2x for the LTM period ending November 2, 2024, down from 4.9x at the end of fiscal 2022 ...

Telix Pharmaceuticals 1H25 NPAT up 860% to $49.9m, FY25 revenue guidance of $1.18-1.23bn vs. $1.02bn consensus, R&D ...

Adjusted Ebitda can be a useful tool, but it should not be relied on as the sole indicator of a company’s financial health.

Q4 2024 Management View Rod Larson, President and CEO, highlighted several achievements, including a record $2.9 billion in order intake for 2024, marking customer confidence in Oceaneering's ...